• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40-3; BONE CEMENT, ANTIBIOTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40-3; BONE CEMENT, ANTIBIOTICS Back to Search Results
Catalog Number 3003940001-3
Device Problem Unsealed Device Packaging (1444)
Patient Problem No Patient Involvement (2645)
Event Date 01/14/2021
Event Type  malfunction  
Manufacturer Narrative
Cmp(b)(4).Report source, foreign - event occurred in (b)(6).5 pictures were received.On the first picture, it can be seen the aluminum pouch with the cement pouch batch number (a925c), which comply with the batch reported in the complaint.The inner pouch sealing is discontinuous and powder leaked.On the 2nd picture, it can be seen the folding box with the batch number (a925ca2503) which comply with the batch reported in the complaint, the aluminium pouch, the monomer ampoule and the patient labels.The inner pouch is not visible but powder is visible.On the 3rd picture, it can be seen the folding box with the batch number (a925ca2503) which comply with the batch reported in the complaint, the aluminium pouch, the monomer ampoule and the patient labels.The inner pouch is not visible.On the 4th picture, it can be seen the aluminum pouch with the cement pouch batch number (a925c), which comply with the batch reported in the complaint.The inner pouch sealing is damaged and seems to be discontinuous on the corner.On the 5th picture, it can be seen the aluminum pouch with the cement pouch batch number (a925c), which comply with the batch reported in the complaint.The product analysis can't be performed as the product was not returned the complaint is related to a well-known event, previously evaluated and investigated.No further investigation is required as per 21 cfr part 820.198 complaint files §(b) and (c).Investigation results concluded that the reported event was due to packaging issue (sealing process).Corrective action has been initiated to address reported issue.A summary of the investigation was sent to the complainant conveying zimmer biomet conclusions.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that before the operation, the sterile package of bone cement product was inspected and powder leakage was found.When other bone cements were opened, powder leakage was found in the same batch.5 boxes of bone cement of the same batch are impacted.No adverse events have been reported as a result of the malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BONE CEMENT R 1X40-3
Type of Device
BONE CEMENT, ANTIBIOTICS
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key11221775
MDR Text Key229580636
Report Number3006946279-2021-00005
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 01/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/25/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2022
Device Catalogue Number3003940001-3
Device Lot NumberA925CA2503
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/15/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/04/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-